210 related articles for article (PubMed ID: 25379698)
1. Correlation between serum levels of IL-15 and IL-17 in patients with idiopathic inflammatory myopathies.
Notarnicola A; Lapadula G; Natuzzi D; Lundberg IE; Iannone F
Scand J Rheumatol; 2015 May; 44(3):224-8. PubMed ID: 25379698
[TBL] [Abstract][Full Text] [Related]
2. Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies.
Notarnicola A; Lapadula G; Natuzzi D; Iannone F
Reumatismo; 2014 Nov; 66(3):215-23. PubMed ID: 25376956
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies.
Tucci M; Quatraro C; Dammacco F; Silvestris F
Clin Exp Immunol; 2006 Oct; 146(1):21-31. PubMed ID: 16968394
[TBL] [Abstract][Full Text] [Related]
4. Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor α expression in muscle tissue of patients with polymyositis or dermatomyositis.
Zong M; Loell I; Lindroos E; Nader GA; Alexanderson H; Hallengren CS; Borg K; Arnardottir S; McInnes IB; Lundberg IE
Ann Rheum Dis; 2012 Jun; 71(6):1055-63. PubMed ID: 22267334
[TBL] [Abstract][Full Text] [Related]
5. The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis.
Yin L; Ge Y; Yang H; Peng Q; Lu X; Zhang Y; Wang G
Clin Rheumatol; 2016 Nov; 35(11):2715-2721. PubMed ID: 27502600
[TBL] [Abstract][Full Text] [Related]
6. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis.
Silva MG; Oba-Shinjo SM; Marie SKN; Shinjo SK
Clin Exp Rheumatol; 2019; 37(4):656-662. PubMed ID: 30620283
[TBL] [Abstract][Full Text] [Related]
7. [Association between cytokines and trichloroethylene-induced hypersensitivity dermatitis].
Zang D; Yi J; Dong HY; Zhou W; Huang XQ; Duan HW; Bin P; Niu Y; Zheng YX; Dai YF
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Sep; 46(9):836-9. PubMed ID: 23157890
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-35 in idiopathic inflammatory myopathies.
Mann H; Kryštůfková O; Zámečník J; Háček J; Hulejová H; Filková M; Vencovský J; Šenolt L
Cytokine; 2021 Jan; 137():155350. PubMed ID: 33128920
[TBL] [Abstract][Full Text] [Related]
9. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
[TBL] [Abstract][Full Text] [Related]
10. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
[TBL] [Abstract][Full Text] [Related]
11. Role of cytokines and chemokines in idiopathic inflammatory myopathies.
De Paepe B; Creus KK; De Bleecker JL
Curr Opin Rheumatol; 2009 Nov; 21(6):610-6. PubMed ID: 19726994
[TBL] [Abstract][Full Text] [Related]
12. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.
Bilgic H; Ytterberg SR; Amin S; McNallan KT; Wilson JC; Koeuth T; Ellingson S; Newman B; Bauer JW; Peterson EJ; Baechler EC; Reed AM
Arthritis Rheum; 2009 Nov; 60(11):3436-46. PubMed ID: 19877033
[TBL] [Abstract][Full Text] [Related]
14. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production.
Sugiura T; Kawaguchi Y; Harigai M; Takagi K; Ohta S; Fukasawa C; Hara M; Kamatani N
J Immunol; 2000 Jun; 164(12):6593-600. PubMed ID: 10843719
[TBL] [Abstract][Full Text] [Related]
15. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
Gono T; Kaneko H; Kawaguchi Y; Hanaoka M; Kataoka S; Kuwana M; Takagi K; Ichida H; Katsumata Y; Ota Y; Kawasumi H; Yamanaka H
Rheumatology (Oxford); 2014 Dec; 53(12):2196-203. PubMed ID: 24970922
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of chemokines in acute myocardial infarction.
Kobusiak-Prokopowicz M; Orzeszko J; Mazur G; Mysiak A; Orda A; Mazurek W
Kardiol Pol; 2005 Apr; 62(4):301-14; discussion 315-6. PubMed ID: 15928736
[TBL] [Abstract][Full Text] [Related]
17. Th1 and Th17 balance in inflammatory myopathies: interaction with dendritic cells and possible link with response to high-dose immunoglobulins.
Tournadre A; Porcherot M; Chérin P; Marie I; Hachulla E; Miossec P
Cytokine; 2009 Jun; 46(3):297-301. PubMed ID: 19303320
[TBL] [Abstract][Full Text] [Related]
18. [Expression of interferon and its correlation with clinical features in idiopathic inflammatory myopathies].
Zu N; Wang GC
Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1157-60. PubMed ID: 21756766
[TBL] [Abstract][Full Text] [Related]
19. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
Barbasso Helmers S; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjörnsson M; Lindvall B; Lundberg IE
Ann Rheum Dis; 2007 Oct; 66(10):1276-83. PubMed ID: 17277004
[TBL] [Abstract][Full Text] [Related]
20. Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up.
Zong M; Dorph C; Dastmalchi M; Alexanderson H; Pieper J; Amoudruz P; Barbasso Helmers S; Nennesmo I; Malmström V; Lundberg IE
Ann Rheum Dis; 2014 May; 73(5):913-20. PubMed ID: 23625983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
